Anin silico-in vitroPipeline Identifying an HLA-A*02:01+KRAS G12V+Spliced Epitope Candidate for a Broad Tumor-Immune Response in Cancer Patients.
Mishto, M., Mansurkhodzhaev, A., Ying, G., Bitra, A., Cordfunke, R.A., Henze, S., Paul, D., Sidney, J., Urlaub, H., Neefjes, J., Sette, A., Zajonc, D.M., Liepe, J.(2019) Front Immunol 10: 2572-2572
- PubMed: 31803176 
- DOI: 10.3389/fimmu.2019.02572
- Primary Citation of Related Structures:  
6O4Z, 6O4Y, 6O51, 6O53 - PubMed Abstract: 
Targeting CD8 + T cells to recurrent tumor-specific mutations can profoundly contribute to cancer treatment. Some of these mutations are potential tumor antigens although they can be displayed by non-spliced epitopes only in a few patients, b ...